{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:36:50Z","timestamp":1789832210011,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018193","name":"Public Foundation of Vaccination Research Center","doi-asserted-by":"publisher","award":["19fk0108066h1702"],"award-info":[{"award-number":["19fk0108066h1702"]}],"id":[{"id":"10.13039\/100018193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.vaccine.2025.127274","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T23:49:14Z","timestamp":1747784954000},"page":"127274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Epidemiology and clinical features of breakthrough varicella in the 9\u00a0years after universal vaccination began in Japan"],"prefix":"10.1016","volume":"59","author":[{"given":"Fumihiko","family":"Hattori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Higashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Ihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127274_bb0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127274_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group a streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.127274_bb0015","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites--United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127274_bb0020","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2004-0012","article-title":"Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States","volume":"114","author":"Davis","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.127274_bb0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127274_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995-2000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127274_bb0035","first-page":"1","article-title":"Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2025.127274_bb0040","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a Meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.127274_bb0045","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127274_bb0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10156-013-0577-x","article-title":"Varicella vaccination in Japan: necessity of implementing a routine vaccination program","volume":"19","author":"Ozaki","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2025.127274_bb0055","author":"National Institute of Infectious Diseases, Japan"},{"key":"10.1016\/j.vaccine.2025.127274_bb0060","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1016\/j.vaccine.2020.09.038","article-title":"Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan","volume":"38","author":"Hattori","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127274_bb0065","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","article-title":"Evaluating the effectiveness of the universal immunization program against varicella in Japanese children","volume":"35","author":"Hattori","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127274_bb0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.127274_bb0075","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1093\/infdis\/jiac214","article-title":"Changing epidemiology of varicella outbreaks in the United States during the varicella vaccination program, 1995-2019","volume":"226","author":"Leung","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127274_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2019.07.009","article-title":"Reliability of direct varicella zoster virus loop-mediated isothermal amplification method for rapid diagnosis of breakthrough varicella","volume":"119","author":"Higashimoto","year":"2019","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2025.127274_bb0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1086\/515638","article-title":"Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis","volume":"178","author":"Kimura","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127274_bb0090","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JCM.00216-08","article-title":"Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification","volume":"46","author":"Higashimoto","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2025.127274_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258391","article-title":"Common communicable diseases in the general population in France during the COVID-19 pandemic","volume":"16","author":"Launay","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127274_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283465","article-title":"Impact assessment of immunization and the COVID-19 pandemic on varicella across Europe using digital epidemiology methods: a descriptive study","volume":"18","author":"Sabale","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127274_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7214a1","article-title":"Seasonality of respiratory syncytial virus - United States, 2017-2023","volume":"72","author":"Hamid","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127274_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1200617","article-title":"Changing patterns of infectious diseases in children during the COVID-19 pandemic","volume":"13","author":"Yang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.127274_bb0115","author":"Ministry of Health, Labour and Welfare, Japan"},{"key":"10.1016\/j.vaccine.2025.127274_bb0120","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/INF.0000000000000821","article-title":"Impact of the US two-dose varicella vaccination program on the epidemiology of varicella outbreaks: data from nine states, 2005-2012","volume":"34","author":"Leung","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.127274_bb0125","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.vaccine.2025.127274_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1542\/peds.75.4.667","article-title":"Long-term protective immunity of recipients of the OKA strain of live varicella vaccine","volume":"75","author":"Asano","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.127274_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.127274_bb0140","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/21645515.2021.1890968","article-title":"Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan","volume":"17","author":"Yasui","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127274_bb0145","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiac390","article-title":"Clinical manifestations of varicella: disease is largely forgotten, but it\u2019s not gone","volume":"226","author":"Dooling","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127274_bb0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases: a household contact study","volume":"292","author":"Seward","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127274_bb0155","doi-asserted-by":"crossref","first-page":"S450","DOI":"10.1093\/infdis\/jiac363","article-title":"Diagnostic and immunologic testing for varicella in the era of high-impact varicella vaccination: an evolving problem","volume":"226","author":"Dollard","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127274_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28569","article-title":"Analysis of the reliability of rapid diagnostic tests for varicella, including breakthrough cases","volume":"95","author":"Higashimoto","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.127274_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127274_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2018.07.003","article-title":"Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect","volume":"92","author":"Toyama","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.vaccine.2025.127274_bb0175","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127274_bb0180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1542\/peds.92.6.833","article-title":"Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka\/Merck varicella vaccine","volume":"92","author":"Bernstein","year":"1993","journal-title":"Pediatrics"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.127274_bb0185","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127274_bb0190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/INF.0b013e31820eae6a","article-title":"Second-dose varicella vaccination coverage in children and adolescents in a managed care organization in California, 2006-2009","volume":"30","author":"Hechter","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.127274_bb0195","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12889-017-4725-6","article-title":"Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance","volume":"17","author":"Hagemann","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.127274_bb0200","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2017.06.065","article-title":"Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era","volume":"35","author":"Suo","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127274_bb0205","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1186\/s12889-016-3738-x","article-title":"Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy","volume":"16","author":"Holl","year":"2016","journal-title":"BMC Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25005717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25005717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:01:41Z","timestamp":1749567701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25005717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":41,"alternative-id":["S0264410X25005717"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127274","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and clinical features of breakthrough varicella in the 9\u00a0years after universal vaccination began in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127274"}}